The development of vaccines against SARS-CoV-2 would be greatly facilitated by the
identification of immunological correlates of protection in humans. However, to date, studies on …

Background Congenital infection with cytomegalovirus (CMV) is an important cause of
hearing, cognitive, and motor impairments in newborns. Methods In this phase 2, placebo-…

Ganciclovir effectively prevents cytomegalovirus (CMV) disease in the first 100 days after
allogeneic hematopoietic stem cell transplantation (HSCT), but late-onset CMV disease is …

Context Cytomegalovirus (CMV) infection is associated with adverse clinical outcomes in
immunosuppressed persons, but the incidence and association of CMV reactivation with …

Background Epidemiologic studies suggest that human herpesvirus 8 (HHV-8) is sexually
transmitted among men who have sex with men; however, the mode of transmission is unclear…

Background Serologic studies indicate that human herpesvirus 6 (HHV-6) infects 90 percent
of children by two years of age. Little is known about the acquisition, virologic course, and …

The novel coronavirus SARS-CoV-2 was first detected in the Pacific Northwest region of the
United States in January 2020, with subsequent COVID-19 outbreaks detected in all 50 …

After its emergence in Wuhan, China, in late November or early December 2019, the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus rapidly spread globally. …

Despite limited genomic diversity, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has shown a wide range of clinical manifestations in different patient populations. …

Multiple laboratory-developed tests (LDTs) and commercially available assays have emerged
to meet diagnostic needs related to the severe acute respiratory syndrome coronavirus 2 (…